Study of Extended Release Niacin/Laropiprant on Lipids (0524A-067)
Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
This is a 12-Week clinical trial in patients with Primary hypercholesterolemia or mixed
dyslipidemia to study the effects of ER niacin/laropiprant on lipids.